ARMATA PHARMACEUTICALS INC (ARMP) Stock Analyst Earnings Estimates
NYSEARCA:ARMP - NYSE Arca - US04216R1023 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.47M 445.12% | 5.51M 23.27% | 4.529M -17.80% | 5.61M 23.87% | 5.61M | -100.00% | 6.212M | 57.419M 824.32% | |
| EBITDA YoY % growth | -22.66M -16.92% | -36.06M -59.14% | -39.918M -10.70% | -44.982M -12.69% | -51.612M -14.74% | N/A | N/A | N/A | |
| EBIT YoY % growth | -23.83M -16.30% | -36.95M -55.06% | -40.89M -10.66% | -44.982M -10.01% | -51.612M -14.74% | -91.858M -77.98% | -53.356M 41.91% | -5.279M 90.11% | |
| Operating Margin | -533.11% | -670.60% | -902.85% | -801.82% | -920.00% | N/A | -858.92% | -9.19% | |
| EPS YoY % growth | -0.97 31.69% | -1.09 -12.37% | -1.80 -65.14% | -0.97 46.17% | -1.73 -78.95% | -0.84 51.76% | -0.45 46.34% | -0.09 79.55% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.36 35.09% | -0.23 66.00% | -0.20 -181.60% | -0.24 -63.20% | -0.36 |
| Revenue Q2Q % growth | 1.591M 4.12% | -100.00% | -100.00% | -100.00% | |
| EBITDA Q2Q % growth | -12.444M -44.58% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -12.39M -29.34% | -10.991M -7.46% | -13.682M -14.84% | -16.931M -73.54% | -24.775M -99.96% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.15 80.00% | -0.29 | 0.14 | 47.48% |
| Q2 2024 Q2Q % growth | 0.25 350.00% | -0.45 | 0.70 | 155.70% |
| Q1 2024 Q2Q % growth | -0.69 -72.50% | -0.32 | -0.37 | -118.22% |
| Q4 2023 Q2Q % growth | -0.55 -89.66% | -0.36 | -0.19 | -54.06% |
| Q3 2023 Q2Q % growth | -0.75 -212.50% | -0.32 | -0.43 | -137.19% |
| Q2 2023 Q2Q % growth | -0.10 61.54% | -0.38 | 0.28 | 73.86% |
| Q1 2023 Q2Q % growth | -0.40 -33.33% | -0.33 | -0.07 | -22.55% |
| Q4 2022 Q2Q % growth | -0.29 -26.09% | -0.29 | 0.00 | -1.54% |
| Q3 2022 Q2Q % growth | -0.24 -9.09% | -0.28 | 0.04 | 14.44% |
| Q2 2022 Q2Q % growth | -0.26 -4.00% | -0.23 | -0.03 | -10.83% |
| Q1 2022 Q2Q % growth | -0.30 -11.11% | -0.21 | -0.09 | -40.06% |
| Q4 2021 Q2Q % growth | -0.23 36.11% | -0.28 | 0.05 | 18.50% |
| Q3 2021 Q2Q % growth | -0.22 29.03% | -0.27 | 0.05 | 18.09% |
| Q2 2021 Q2Q % growth | -0.25 3.85% | -0.27 | 0.02 | 7.51% |
| Q1 2021 Q2Q % growth | -0.27 44.90% | -0.33 | 0.06 | 17.28% |
| Q4 2020 Q2Q % growth | -0.36 25.00% | -0.30 | -0.06 | -20.32% |
| Q3 2020 Q2Q % growth | -0.31 57.53% | -0.24 | -0.07 | -28.42% |
| Q2 2020 Q2Q % growth | -0.26 53.57% | -0.38 | 0.12 | 31.72% |
| Q1 2020 Q2Q % growth | -0.49 68.18% | -0.30 | -0.19 | -62.84% |
| Q4 2019 Q2Q % growth | -0.48 | -0.74 | 0.26 | 35.09% |
| Q3 2019 Q2Q % growth | -0.73 | -0.46 | -0.27 | -57.29% |
| Q2 2019 Q2Q % growth | -0.56 | -0.37 | -0.19 | -50.42% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 2.973M 142.69% | 918K | 2.055M | 223.86% |
| Q2 2024 Q2Q % growth | -100.00% | 1.158M | -1.158M | -100.00% |
| Q1 2024 Q2Q % growth | 966K 21.36% | 1.122M | -156K | -13.90% |
| Q4 2023 Q2Q % growth | 1.528M 45.52% | 877.2K | 650.8K | 74.19% |
| Q3 2023 Q2Q % growth | 1.225M -8.58% | 973.59K | 251.41K | 25.82% |
| Q2 2023 Q2Q % growth | 980K -47.87% | 1.846M | -866K | -46.91% |
| Q1 2023 Q2Q % growth | 796K -35.81% | 1.815M | -1.019M | -56.14% |
| Q4 2022 Q2Q % growth | 1.05M 6.06% | 1.703M | -653K | -38.34% |
| Q3 2022 Q2Q % growth | 1.34M 7.20% | 1.673M | -333K | -19.90% |
| Q2 2022 Q2Q % growth | 1.88M 60.68% | 1.134M | 746K | 65.78% |
| Q1 2022 Q2Q % growth | 1.24M 15.89% | 1.03M | 210K | 20.39% |
| Q4 2021 Q2Q % growth | 990K 98.00% | 1.004M | -14K | -1.39% |
| Q3 2021 Q2Q % growth | 1.25M 331.03% | 1.098M | 152K | 13.84% |
| Q2 2021 Q2Q % growth | 1.17M 3,800.00% | 418.2K | 751.8K | 179.77% |
| Q4 2020 Q2Q % growth | 500K | 207.06K | 292.94K | 141.48% |
| Q3 2020 Q2Q % growth | 290K | 594.997K | -304.997K | -51.26% |
| Q2 2020 Q2Q % growth | 30K | 765K | -735K | -96.08% |
| Q1 2020 Q2Q % growth | 510K | -510K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 6.86% | 6.86% |
| Revenue | 0% | 37.99% | 0% | 83.33% |